AVALO THERAPEUTICS INC COM NEW is a security (CUSIP 05338F306) tracked across SEC portfolio filings. 102 institutional managers reported $472.3M on Form 13F as of 2026-06-30; 7 registered fund positions totaling $18.8M via N-PORT as of 2026-05-31.
Showing 15 of 102 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| FMR LLC | BOSTON, MA | $43.0M | 2,879,481 |
| Caligan Partners LP | New York, NY | $24.4M | 1,635,023 |
| BVF INC/IL | San Francisco, CA | $24.4M | 1,632,845 |
| Avoro Capital Advisors LLC | New York, NY | $21.1M | 1,410,000 |
| Affinity Asset Advisors, LLC | New York, NY | $20.0M | 1,340,840 |
| Logos Global Management LP | San Francisco, CA | $19.4M | 300,000 |
| Nantahala Capital Management, LLC | New Canaan, CT | $18.4M | 1,235,000 |
| UBS Group AG | Zurich, V8 | $17.0M | 1,141,980 |
| Caption Management, LLC | OKLAHOMA CITY, OK | $16.2M | 455,000 |
| VANGUARD GROUP INC | Valley Forge, PA | $14.6M | 804,084 |
| Point72 Asset Management, L.P. | Stamford, CT | $13.7M | 916,142 |
| FARALLON CAPITAL MANAGEMENT LLC | SAN FRANCISCO, CA | $13.7M | 916,000 |
| RTW INVESTMENTS, LP | NEW YORK, NY | $12.8M | 856,962 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Boston, MA | $12.8M | 854,000 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $12.5M | 835,484 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. | T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | $10.1M | 12.56% |
| T. Rowe Price Small-Cap Value Fund, Inc. | T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | $4.7M | 5.09% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $2.6M | 45.70% |
| Fidelity Series Total Market Index Fund | Fidelity Concord Street Trust | $824K | 0.07% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $457K | 4.52% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $92K | 0.12% |
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $16 | 0.00% |